| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0098 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |